the aid library

LIST OPTIONS

Filter

2728

A shot at ending AIDS — How new long-acting medicines could revolutionize the HIV response

UNAIDS (2025) C1

Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could also be key for 40 million people living with HIV around the world who need better options for trea... more

External Link

Financing HIV Programming: How Much Should Low And Middle-Income Countries and their Donors Pay?

Galarraga, O.; V. J. Wirtz; Y. Santa-Ana-Tellez et al. PLOS One (2013) C1

Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t... more

Download (230)

View PDF (371)

Response to the COVID-19 Pandemic in the Americas Response Strategy and Donor Appeal January – December 2021

Pan American Health Organisation PAHO (2020) C_WHO

While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i... more

Download (419)

View PDF (585)

Country perceptions for implementation of the new multi-drug resistant TB (MDR-TB) medicines.

F. Brigden; M. Ya Diul; R. H.Crespo, L. Ditiu, A. Kurats, etc al. Stop TB Partnership to reach; Medecins Sans Frontieres (2017) C1

Report: A survey conducted among the 27 high MDR-TB burden countries. March – July 2015 Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF). Accessed November 2017.

External Link

International Assistance for HIV/AIDS in the Developing World: Taking Stock of the G8, Other Donor Governments and the European Commission

Kates J. Kaiser Family Foundation (2006) CC

As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t... more

Download (1248)

View PDF (3418)

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2022) C_WHO

Issue Brief 8th edition.

Download (963)

View PDF (1613)

Malawi: Assessment of the Logistics and Supply Chain Management of Anti-TB Medicines

Chana, R USAID (2009) C1

Download (423)

View PDF (434)

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO

Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t... more

Download (166)

View PDF (343)

Global update on implementation of preventive chemotherapy against neglected tropical diseases (‎NTDs)‎ in 2023 and status of donated medicines for NTDs in 2024

World Health Organization WHO (2024) C_WHO

760 WEEKLY EPIDEMIOLOGICAL RECORD, NOS. 51/52, 20 DECEMBER 2024, pp.760-769. In French and English

External Link

Harmonization of community health worker programs for HIV: A four-country qualitative study in Southern Africa

J.-W. De Neve; H. Garrison-Desany; K. G. Andrews; et al. PLOS Medicine (2017) CC

Research Article PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002374 August 8, 2017

Download (48)

View PDF (23)

Children and malaria: treating and protecting the most vulnerable

Medicines for Malaria Venture MMV (2019) C1

This document by Medicines for Malaria Venture (MMV) highlights the significant burden of malaria on children worldwide, emphasizing the need for effective prevention, diagnosis, and treatment strategies. It reviews current challenges and progress in combating pediatric malaria, advocating for conti... more

Download (231)

View PDF (319)

Tracking Official Development Assistance for Reproductive Health in Conflict-Affected Countries

Patel P.; Roberts B.; Gury S. et al. PLOS Medecine (2009) CC

Reproductive health needs are particularly acute in countries affected by armed conflict. Reliable information on aid investment for reproductive health in these countries is essential for improving the efficiency and effectiveness of aid. The purpose of this study was to analyse official developm... more

Download (366)

View PDF (446)

Global child and adolescent mental health: The orphan of development assistance for health

Lu C., Li Z.; Patel V. PLOS Medecine (2018) CC

More than 40% of the world population is 24 years old or younger, the vast majority of whom live in low- and lower middle–income countries. Globally, a quarter of disability-adjusted life years (DALYs) for mental disorders and substance abuse is borne by this age group and about 75% of mental diso... more

External Link

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

Suárez, C., Nolder, D., García-Mingo, A. et al. Research and reports in tropical medicine (2022) CC

Research and Reports in Tropical Medicine 2022:13 25–40. Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po... more

External Link

Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011–2013: Analysis of Annual Surveys at the Facility Level

V. Habiyambere; N. Ford; D. Low-Beer; et al. PLOS Medicine (2016) CC

PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016

Download (374)

View PDF (454)

Balancing Community and Hospital Care: A Case Study of Reforming Mental Health Services in Georgia

Makhashvili, N.; van Voren, R. PLOS Medicine (2013) CC

PLoS Med 10(1): e1001366. https://doi.org/10.1371/journal.pmed.1001366 Published: January 8, 2013

Download (246)

View PDF (247)

Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review

R. Granich; S. Gupta; I. Hall; et al. Plos Medicine (2017) CC

Research Article PLOS Medicine | DOI:10.1371/journal.pmed.1002253 April 4, 2017

Download (383)

View PDF (732)

Guatemala National Disability Study (Endis 2016) Main Report

International Centre for Evidence in Disability (ICED) London School of Hygiene & Tropical Medicine (2017) C2

Download (1142)

View PDF (1027)

Philippines: National tuberculosis control program laboratory network strategic plan 2013-2016

Noel G. Macalalad, Ma. Cecilia G. Ama, Arthur B. Lagos et al. Research Institute for Tropical Medicine National Tuberculosis Reference Laboratory (2013) C1

External Link

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines recommended

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended